ASCO
@ASCO
Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ≠ endorse.
We are grateful to our ~44,000 attendees who made #ASCO25 a success & the place to be! With nearly 40% joining us from outside the U.S., we are truly a global community united by our shared goal of improving #CancerCare & pt outcomes around the world. A heartfelt ‘thank you.’ 💗
In the era of EV plus pembro, where does radical cystectomy fit into treatment plans for patients with urothelial carcinoma? @siadaneshmand provides a detailed overview for #ASCODailyNews: brnw.ch/21wUqpv

A new @JCO_ASCO report calls for a paradigm shift in how cancer drug dosages are determined, concluding that the long-standing practice of using the "maximum tolerated dose" may be outdated, harmful to patients, ill-suited for modern cancer therapies ➡️ brnw.ch/21wUp7x

The updated Oncology Medical Home Standards are now live in @JCOOP_ASCO. A joint initiative of ASCO & @oncologyCOA, the standards were introduced in 2021 & provide a framework for onc practices to deliver high-quality, patient-centered cancer care. ➡️brnw.ch/21wUoWm

The first session of the 2025-2026 @ASCO Leadership Development Program cohort starts today. I’m thrilled to serve as a mentor again this year. It’s inspiring to get to work with such a talented group of participants and mentors - and the ASCO staff of course!
The draft guideline protocol, Perioperative Treatment in RCC at High-Risk of Recurrence, is now available for open comment. Provide your feedback to us by August 1. Learn more: brnw.ch/21wUmBF

New draft guideline alert! 🚨 ASCO's "ctDNA Testing in Solid Tumors and Lymphoma" is open for comments until August 4. Share your feedback: brnw.ch/21wUkJb

My favorite meeting of the year in the beautiful San Francisco #GI26. And when @MaryFengMD is in charge of the program… it’s sure to be stellar!! @ASCO
Submit your abstracts and plan to join us in SF for @ASCO #GI26! We are planning a program to address both scientific and practical challenges, as we move toward conquering cancer.
I had the pleasure of meeting w/ @ASCO staff last week in which I introduced my presidential theme for 2025-2026: "The Science and Practice of Translation: Improving Cancer Outcomes Worldwide." Excited to roll this out over the course of the year, and of course, at #ASCO26!
Improving #OncologyCare! Check out our latest standards update on the Oncology Medical Home. Read the full article: brnw.ch/21wUjjy

Join us in congratulating the following members on earning the Fellows of ASCO (FASCO) distinction last quarter! We are grateful for their extraordinary volunteer service, dedication, and commitment to ASCO. Learn more about FASCO distinction: brnw.ch/21wUiVu



Meet the moment & help shape the future of GI cancer care by submitting an abstract to #GI26. Whether you have a study in progress or late-stage clinical trial, this meeting offers oral & poster presentation opportunities. #gicsm Submit today: brnw.ch/21wUg0m

🚨 Just issued! Our new living guideline update on therapy for Stage IV #NSCLC without driver alterations is here. Stay up-to-date with the latest recommendations. Read the full article: brnw.ch/21wUfz5

🚨 Just issued! Our new living guideline update on therapy for Stage IV #NSCLC with driver alterations is here. Stay up-to-date with the latest recommendations. Read the full article: brnw.ch/21wUekt

This state session #ASCOAdvocacy has been busy! By working with the State Affiliates and coalition partners, we engaged on issues affecting cancer patients and care providers state-by-state. See what we've done in the first half of 2025: brnw.ch/21wUdXd

The DESTINY-Gastric04 trial, presented at #ASCO25, established T-DXd as a preferred second-line treatment option for HER2+ metastatic gastric cancer/GEJA. For #ASCODailyNews, @KoheiShitara & Dr. Izuma Nakayama evaluate these important findings: brnw.ch/21wUdDp

New draft guideline alert! 🚨 Our "Systemic Treatment of Thyroid Guideline" is open for comments until July 30. Share your feedback: brnw.ch/21wUctu

🎙@hoperugo of @cityofhope, @keri_brenner of @StanfordMed & @MikolajRode of @UniofOxford discuss strategies to help clinicians respond to suffering in a more patient-centered & therapeutic way on the ASCO Education #BytheBook Podcast. #ASCOEdBook Listen: brnw.ch/21wUbS9

The 2026 Medicare physician fee schedule proposal includes a nearly 4% reimbursement increase, new efficiency adjustment, telehealth changes, & more provisions that will impact #cancer care. Read the initial #ASCOAdvocacy analysis: brnw.ch/21wUaCG

🎙 Dr. Paul Hanona and @DrBonillaOnc of @mystlukes & @MassiveBio discuss responsible AI integration and the future of AI-enabled cancer care on the latest episode of the #ASCODailyNews Podcast: brnw.ch/21wUay1

ICYMI: Dr. Robert A. Figlin, @OncNewsCentral's Peer-Spectives podcast host, spoke to our CEO @CliffordHudis about challenges academic oncologists face, including burnout & unrealistic job expectations & how to better support them. Listen Now: brnw.ch/21wU8Jl
